Latest Interviews
Showing 1891–1905 of 4,790 transcripts.
Clear all filtersNilan Peiris: What Growth Hacks Worked and What Did Not, from Wise CPO | E1182
Wise defines product marketing as closing the gap between perceived and actual value to drive order-of-magnitude differentiation, leveraging a "Purple Cow" strategy that prioritizes being distinct rather than marginally better. The company targets the $1T consumer and $10T SMB cross-border markets by maintaining cost leadership and utilizing a hybrid growth engine where 70% of acquisition stems from word-of-mouth and SEO. Strategic tactics include visualizing savings to build trust, diversifying marketing channels after achieving unit economics efficiency, and evolving its organizational structure to support a dual-brand vision focused on both consumer trust and B2B API infrastructure.
Text-to-CAD: AI Revolutionizing Hardware Design with Jordan Noone of Zoo
Jordan Noone, Molly O'Shea, Jessie Frazelle, Ben Horowitz, Vinod Khosla, Alfred Lin, Mike Maples, Roger Ehrenberg
Zoo is launching a cloud-based, GPU-optimized computational geometry engine designed to replace manual, labor-intensive CAD workflows with AI-driven automation for the $1 trillion hardware development market. Led by Aerospace engineer and Relativity Space co-founder Jordan Noon alongside CEO Jess, the company has already generated 13,000 CAD files via its generative AI interface while securing $6 million in funding from investors including GitHub co-founder Tom Preston-Werner. The firm plans to expand its workforce to 50 employees and construct an in-house factory to integrate Design for Manufacturability checks directly into its machine learning models.
- The Diary Of A CEO2h 5m
The Doctor That Got Banned For Speaking Out:“We've Been Lied To About Medication!” Dr Aseem Malhotra
Dr. Asim Malhotra argues that the global rollout of mRNA vaccines has produced a catastrophic net negative effect on society, citing independent analyses that suggest these shot increased heart attack risks and serious harm rates far beyond historical safety benchmarks. He contrasts this pharmaceutical-driven model with his advocacy for lifestyle interventions, such as improved diet and stress reduction, which he claims could reverse arterial blockages and address the root causes of chronic heart disease. Malhotra contends that commercial interests and regulatory capture have suppressed these safer, non-pharmaceutical approaches, urging a systemic shift toward transparency and metabolic health to restore public trust.
Jason Lemkin: Crowdstrike, WTF Happens From Here? Wiz Rejects Google’s $23BN Acquisition Offer|E1181
Wiz founders rejected a $23.5 billion Google acquisition offer to pursue a higher valuation IPO, citing antitrust risks and management distraction costs, while CrowdStrike suffered a $34 billion market cap loss following a global technical outage that halted operations. Venture capital dynamics face a liquidity drought as late-stage funds struggle to exit investments amid prolonged market delays, prompting experts like Jason Calacanis to advise accepting near-exit acquisition offers despite potential long-term upside from IPOs. Simultaneously, the legal tech sector is rapidly evolving with AI-native startups like Harvey AI achieving triple-digit growth, leading to predictions that core AI features will become commoditized by 2025.
- All-In Podcast26 min
The Besties Take Napa | All-In Special
Speakers including David Friedberg, Chamath Palihapitiya, and David Sachs predict a future where AI enables small teams to rebuild the software stack by replacing human coding and administrative roles with automated workflows, potentially rendering traditional SaaS obsolete. The discussion highlights critical enterprise AI hurdles regarding data context windows, proposing Retrieval Augmented Generation as a necessary optimization, while advocating for an investment philosophy that favors intense focus on single verticals over diversified portfolios. These technical and strategic insights were exchanged at a high-cost Milan gathering, which also featured personal reflections on the "bionic" nature of work, poker as a decision-making tool, and a surprise birthday celebration for Friedberg.
- 80,000 Hours1h 23m
Off the Clock #5: Leaving 80k with Maria Gutierrez Rojas
Maria Gutierrez Rojas, Matt Rudin, Bella Forestall, Cody Fenwick
Former ADK employee Maria Gutierrez Rojas joins host Matt Rudin and guests Bella Forestall and Cody Fenwick on *Mic Discipline* to analyze the organization's design choices, her departure from the role, and the phenomenon of "Club Club" dynamics. The discussion contrasts ADK's utility-focused web strategy with the team's internal philosophical conflicts, while Rojas details her transition to Open Philanthropy driven by a preference for clear incentives over advocacy work. Throughout the episode, the group examines themes of loneliness, religious influences on moral reasoning, and the tension between Effective Altruism's public posture and individual psychological needs.
- a16z24 min
Mark Casey (Capital Group): Public Market and Macro Perspectives
Capital's long-term value investing strategy employs a four-to-eight-year horizon and a compensation structure weighted toward multi-year results to prioritize earnings convergence over short-term market noise. The firm actively manages portfolio construction by identifying unstoppable secular trends like cloud computing and e-commerce while criticizing deceptive metrics such as adjusted EBITDA in favor of free cash flow per share. Additionally, the approach emphasizes superior capital allocation by citing industry leaders like Warren Buffett and Hock Tan, while maintaining bullish positions on high-moat fintech and semiconductors tied to the AI revolution.
- Goldman Sachs44 min
Private credit investing with Ares Management’s Mike Arougheti
CEO Mike Arrighetti leads Ares Management, a global alternative asset firm overseeing over $400 billion in assets and establishing itself as a premier direct lender through active origination strategies. Under his 2018 succession of co-founder Bennett Rosenthal, the firm has institutionalized a partnership culture while expanding its private credit footprint across aging demographics, regulatory shifts, and emerging markets in Asia and Latin America. Arrighetti projects the sector will sustain 10–15% annual growth driven by bank disengagement and infrastructure demands, a trajectory that aligns with the firm's focus on floating-rate resilience and its broader charitable initiatives.
- Sequoia Capital52 min
Klarna CEO Sebastian Siemiatkowski on Getting AI to Do the Work of 700 Customer Service Reps
Sebastian Siemiatkowski, Sonya Huang, Pat Grady
Klarna CEO Sebastian Gunnarsson leveraged a direct partnership with OpenAI to transform the payments platform's dispute resolution from a 14-minute human process to a two-minute autonomous AI system, resulting in a $40 million annual profit increase and the elimination of 700 contracts. Beyond customer service, the company has centralized its operations into a proprietary knowledge graph to power an internal chatbot named Kiki while simultaneously replacing legacy enterprise software to accelerate marketing campaigns from months to days. Gunnarsson frames this strategic shift not as a total replacement of human roles but as a necessary evolution to enforce higher documentation standards and create a "digital financial assistant" that proactively drives savings for consumers.
- 80,000 Hours25 min
Highlights: Hugo Mercier on why gullibility and misinformation are overrated
Hugo Mercier's analysis reframes human communication as an evolutionary adaptation prioritizing discernment over gullibility, where trust is calibrated through competence and long-term incentives rather than a constant arms race between sender and receiver. The presentation identifies the primary danger of AI not as sophisticated persuasion but as information noise that erodes credibility, arguing instead that social motivation drives belief systems like conspiracy theories while genuine skepticism remains the norm. Ultimately, empirical evidence suggests that open verification facilitates belief updating in the face of strong arguments, with the "backfire effect" being an exceptionally rare exception rather than a widespread cognitive failure.
- Goldman Sachs10 min
Biopharma opportunities and macro challenges: A check-up on the industry
Asad Haider, Chris Shibutani, Salveen Richter, Sylvain
Major pharmaceutical and biotech leaders converged to identify GLP-1 agonists and AI integration as primary drivers for a market revised upward to $130 billion, while strategically addressing patent cliffs through aggressive external collaborations and M&A targeting metabolic and neurology assets. Although the biotech IPO window has reopened with nine clinical-stage offerings, investor sentiment remains sensitive to interest rate trajectories and the need for immediate commercial validation of AI-driven discoveries. Consequently, industry capital allocation prioritizes balancing near-term revenue generators with long-term growth catalysts to navigate complex clinical challenges in the central nervous system and cardiovascular disease sectors.
- The Economist25 min
Joe of good faith: Biden bows out
Joe, Biden, Kamala Harris, Dr Ruth, Rosie Bloor, Jason Palmer, John Priddo, Leo Morani, Anne Rowe, Jerry
Following a debate performance that eroded public confidence, President Joe Biden withdrew from the 2024 race and immediately endorsed Vice President Kamala Harris, positioning her to potentially become the first female president despite her lack of a proven national election record. While political analysts warn that the public still associates Harris with Biden's approval ratings and note her previous unsuccessful primary run, the party faces a competitive field led by governors and senators before the mid-August convention. Concurrently, the administration's legacy remains precarious as the upcoming election could overshadow recent legislative victories in climate and economic recovery, leaving the Democratic strategy to pivot on whether a competent opponent can capitalize on Donald Trump's polarizing nature.
- Milken Institute58 min
Traversing Real Estate Realities | Milken Institute Global Conference 2024
Ted Seides, Jase Auby, Maggie Coleman, Joshua Morris, Tim Sloan, Joshua Weintraub
Leading institutional investors and asset managers converged to analyze a commercial real estate market defined by a dislocation between elevated interest rates and slower fundamental growth, creating distinct opportunities in data centers, single-family rentals, and distressed senior credit while navigating significant risks in oversupplied office sectors. Speakers highlighted how a generational housing shortage and a looming "wall of maturities" for $2.6 trillion in commercial loans are driving a structural shift where private non-bank lenders replace exiting regional banks to fund high-yield strategies. The panel concluded that prioritizing use-based assets with defensive demographics over traditional property classifications offers a more resilient path through the current higher-for-longer rate environment, provided investors maintain strict valuation discipline against cyclical volatility.
- Milken Institute1h 1m
The Next Wave of Immunotherapy and Cancer Treatments | Milken Institute Global Conference 2024
Marc Hurlbert, Gina Carithers, Friedrich Graf Finckenstein, Anusha Kalbasi, Connie Pfeiffer, Sunil Verma, Frederick Finckenstein, Neil Verma, Anusha Singhal
Major research organizations like the Melanoma Research Alliance and the Prostate Cancer Foundation have funded over $1 billion in studies that pioneered immune checkpoint inhibitors and novel T-cell therapies for melanoma and prostate cancer. Recent advancements include the approval of Iovance's tumor-infiltrating lymphocyte treatment for solid tumors and the development of bispecific agents that reduce manufacturing delays, though challenges regarding high costs, autoimmune side effects, and the need for broader genetic screening persist. Clinical strategies are shifting toward neoadjuvant trials and combination therapies with antibody-drug conjugates to improve patient outcomes before standard care options are exhausted.
- All-In Podcast1h 16m
Trump assassination attempt, Secret Service failure, Inside the RNC, VC liquidity problem
Trump, Chamath, Jason, Friedberg, Nick, Freeburg
Following a failed assassination attempt by Thomas Matthew Crooks that killed one attendee and injured others, the Republican National Convention solidified a coalition between MAGA populists and tech interests by selecting J.D. Vance as Donald Trump's vice-presidential running mate. The hosts analyzed the event's security failures, debated the impact of political rhetoric on the violence, and examined the administration's potential shift toward isolationist trade policies and regulatory changes regarding Big Tech. Simultaneously, the discussion highlighted significant venture capital developments, including Stripe's liquidity deal and Google's potential acquisition of Wiz, while predicting President Biden's imminent withdrawal from the race due to declining donor confidence.